Parental and child perceptions of anxiety and depression in children with epilepsy

Overview

About this study

This study aims to assess the level of anxiety and depression in children with epilepsy and compare to the level of anxiety and depression perceived by family by using validated, standardized measures as both comorbid conditions can significantly impact both quality of life and disease course.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Subject population (children, adults, groups): Children ages 8 years through 18 years and one of their parents or guardians.

Inclusion Criteria:

1. Patient age between 8 and 17 years.

2. Parent or guardian is accompanying the patient.

3. Diagnosis of epilepsy.

4. Intelligence quotient/developmental quotient of 70 or higher.

Exclusion Criteria:

1. Children less than 8 years old or greater than 17 years old.

2. No parent or guardian available at the time of screening.

3. Patients who have not been given a diagnosis of epilepsy.

4. IQ <70.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Anthony Fine, M.D.	Open for enrollment	Contact information: Anthony Fine M.D. Fine.Anthony@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Anthony Fine, M.D.

Open for enrollment

Contact information:

Anthony Fine M.D.

Fine.Anthony@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials